THE INFLUENCE OF HYPOPHYSECTOMY AND OF SUBSEQUENT TREATMENT WITH CHORIONIC GONADOTROPHIN ON FOLLICLES OF DIFFERENT SIZE IN THE OVARY OF THE RAT

1949 ◽  
Vol 3 (1) ◽  
pp. 89-104 ◽  
Author(s):  
F. J. A. PAESI
Keyword(s):  
Subsequent Treatment ◽  
Chorionic Gonadotrophin

INCIDENCE AND RATE OF APPEARANCE AND DISAPPEARANCE OF ANTIGONADOTROPHIN IN THE BLOOD OF PATIENTS TREATED WITH PREGNANT MARES' SERUM GONADOTROPHIN

1964 ◽  
Vol 45 (4_Suppl) ◽  
pp. S235-S242 ◽  
Author(s):  
Erling Østergaard
Keyword(s):  
Effective Treatment ◽  
Subsequent Treatment ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Present Series ◽  
Human Pituitary ◽  
Continuous Therapy ◽  
Blood Samples ◽  
Intensive Courses ◽  
Blood Specimens

ABSTRACT Thirty-eight patients with amenorrhoea were treated with repeated series of injections of pregnant mares' serum gonadotrophin + human chorionic gonadotrophin. Each course consisted of 5 injections of 1500 IU or 3000 IU of serum gonadotrophin, Antex®, followed by 3 injections of 1500 IU or 3000 IU of chorionic gonadotrophin, Physex®, If required, this treatment was repeated at a few months' intervals, in some cases up to 5 times. After each course, the blood was studied for the presence of antigonadotrophin to Antex. Blood specimens were drawn in all cases 21 days after the last injection of Antex. Antigonadotrophin was found to be present in one out of 15 patients after the 1st course, in 8 out of 20 after the 2nd course, in 13 of 16 after the 3rd, and in 6 of 6 patients after the 4th and 5th courses. Progonadotrophic activity was demonstrated in the blood of 6 patients after the 1st course, in 4 after the 2nd course, and in one on the 10th day after the 3rd course. In 6 cases blood samples were obtained also immediately before, during and immediately after the treatment. Three showed, during the 3rd, 4th and 5th course respectively, antigonadotrophin in the blood even before the last injection of Antex. These courses were ineffective, and no patient got menstrual bleeding as a result of the 4th or 5th course. Some patients developed bleeding after the 3rd treatment, although antigonadotrophin was demonstrated in the blood on the 21st day. In these cases the antigonadotrophin presumably did not form until the injections of Antex had exerted their effect. The antigonadotrophin occurring during these therapeutic courses inactivates only serum gonadotrophin and limits effective treatment by this gonadotrophin to about 4 weeks in continuous therapy and to 3 of the brief, intensive courses employed in the present series. Apart from this, the formation of this antigonadotrophin did not have harmful consequences. It disappears from the blood within a period of a few months, occasionally up to about a year, and it does not prevent subsequent treatment with human pituitary gonadotrophin from being effective.

Surgery for Lung Cancer and the Consequences for the Swallow

2016 ◽  
Vol 1 (13) ◽  
pp. 162-168
Author(s):  
Pippa Hales ◽  
Corinne Mossey-Gaston
Keyword(s):  
Lung Cancer ◽  
Treatment Options ◽  
Vocal Cord Palsy ◽  
Subsequent Treatment ◽  
Physiological Reserve ◽  
Palliative Phase ◽  
And Function ◽  
The Impact ◽  
Swallow Function

Lung cancer is one of the most commonly diagnosed cancers across Northern America and Europe. Treatment options offered are dependent on the type of cancer, the location of the tumor, the staging, and the overall health of the person. When surgery for lung cancer is offered, difficulty swallowing is a potential complication that can have several influencing factors. Surgical interaction with the recurrent laryngeal nerve (RLN) can lead to unilateral vocal cord palsy, altering swallow function and safety. Understanding whether the RLN has been preserved, damaged, or sacrificed is integral to understanding the effect on the swallow and the subsequent treatment options available. There is also the risk of post-surgical reduction of physiological reserve, which can reduce the strength and function of the swallow in addition to any surgery specific complications. As lung cancer has a limited prognosis, the clinician must also factor in the palliative phase, as this can further increase the burden of an already compromised swallow. By understanding the surgery and the implications this may have for the swallow, there is the potential to reduce the impact of post-surgical complications and so improve quality of life (QOL) for people with lung cancer.

Minimizing Carry-Over Effects After Treatment Failure and Maximizing Therapeutic Outcome

2014 ◽  
Vol 222 (3) ◽  
pp. 171-178 ◽  
Author(s):  
Mareile Hofmann ◽  
Nathalie Wrobel ◽  
Simon Kessner ◽  
Ulrike Bingel
Keyword(s):  
Treatment Failure ◽  
Human Subjects ◽  
Subsequent Treatment ◽  
Clinical Samples ◽  
Administration Route ◽  
Healthy Human ◽  
Negative Experiences ◽  
Analgesic Treatment ◽  
Balanced Design ◽  
Carry Over

According to experimental and clinical evidence, the experiences of previous treatments are carried over to different therapeutic approaches and impair the outcome of subsequent treatments. In this behavioral pilot study we used a change in administration route to investigate whether the effect of prior treatment experience on a subsequent treatment depends on the similarity of both treatments. We experimentally induced positive or negative experiences with a topical analgesic treatment in two groups of healthy human subjects. Subsequently, we compared responses to a second, unrelated and systemic analgesic treatment between both the positive and negative group. We found that there was no difference in the analgesic response to the second treatment between the two groups. Our data indicate that a change in administration route might reduce the influence of treatment history and therefore be a way to reduce negative carry-over effects after treatment failure. Future studies will have to validate these findings in a fully balanced design including larger, clinical samples.

THE PRECISION OF THE OVARIAN ASCORBIC ACID DEPLETION TEST FOR LUTEINIZING HORMONE

1963 ◽  
Vol 43 (1) ◽  
pp. 155-160
Author(s):  
Jørgen Falck Larsen ◽  
Christian Hamburger
Keyword(s):  
Ascorbic Acid ◽  
Luteinizing Hormone ◽  
Clinical Analysis ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin

ABSTRACT Various modifications of the Parlow test for luteinizing hormone (ovarian ascorbic acid depletion in rats) were tried. Human chorionic gonadotrophin was used instead of hypophyseal luteinizing hormone. The precision of the method was found to be so low, however, that the test could not be used for routine clinical analysis. The low precision found in this and other laboratories is thought to be due to the strains of rats used.

TRANSPORT OF CHORIONIC GONADOTROPHIN (HCG) IN BLOOD

1961 ◽  
Vol 36 (3) ◽  
pp. 438-442
Author(s):  
D. Nagy ◽  
I. Gáti ◽  
G. Keller
Keyword(s):  
Chorionic Gonadotrophin ◽  
Globulin Fraction ◽  
Preparative Electrophoresis ◽  
Beta Globulin

ABSTRACT It has been shown by preparative electrophoresis that in the pregnancy serum HCG is transported in the beta globulin fraction. The linkage is believed to be adsorptive in nature.

STUDIES ON THE AROMATISATION OF NEUTRAL STEROIDS IN PREGNANT WOMEN

1964 ◽  
Vol 45 (4) ◽  
pp. 535-559 ◽  
Author(s):  
E. Bolté ◽  
S. Mancuso ◽  
G. Eriksson ◽  
N. Wiqvist ◽  
E. Diczfalusy
Keyword(s):  
Pregnant Women ◽  
Comparative Studies ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Radioactive Material ◽  
Placental Barrier ◽  
Therapeutic Abortion ◽  
Limited Ability ◽  
Better Than

ABSTRACT In 15 cases of therapeutic abortion by laparotomy the placenta was disconnected from the foetus and perfused in situ with tracer amounts of radioactive dehydroepiandrosterone (DHA), dehydroepiandrosterone sulphate (DHAS), androst-4-ene-3,17-dione (A), testosterone (T) and 17β-oestradiol (OE2). Analysis of the placentas, perfusates and urine samples revealed an extensive aromatisation of DHA, A and T; more than 70% of the radioactive material recovered was phenolic, and at least 80 % of this phenolic material was identified as oestrone (OE1), 17β-oestradiol (OE2) and oestriol (OE3), the latter being detected only in the urine. Comparative studies indicated that A and T were aromatised somewhat better than DHA and that all three unconjugated steroids were aromatised to a much greater extent than DHAS. Radioactive OE1 and OE2 were isolated and identified in the placentas and perfusates, but no OE3, epimeric oestriols, or ring D ketols could be detected in these sources, not even when human chorionic gonadotrophin (HCG) was added to the blood prior to perfusion. Lack of placental 16-hydroxylation was also apparent when OE2 was perfused. Regardless of the precursor perfused, there was three times more OE2 than OE1 in the placenta and three times more OE1 than OE2 in the perfusate. This was also the case following perfusion with OE2. The results are interpreted as suggesting the existence in the pregnant human of a placental »barrier« limiting the passage of circulating androgen. The barrier consists of a) limited ability to transfer directly DHAS and b) an enzymic mechanism resulting in the rapid and extensive aromatisation of the important androgens DHA, A and T.

Sign in / Sign up

Export Citation Format

Share Document